Lantern Pharma Inc.

NASDAQ:LTRN

3.91 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 12.97718.35821.93825.57228.42332.47937.20239.25843.36346.65251.52454.66961.35481.37419.22920.80323.7980.6341.232-0.445
Short Term Investments 20.2862019.36519.35419.52619.06117.99418.56918.78718.56519.20119.16418.2350000000.89
Cash and Short Term Investments 33.26238.35841.30344.92647.94951.5455.19657.82762.14965.21670.72573.83379.58981.37419.22920.80323.7980.6341.2320.445
Net Receivables 000.860000.5920.3050.3390.2280.181000000000
Inventory 000000-0.592-0.305-0.339-0.228-0.181000000000
Other Current Assets 2.0291.1131.1792.52.5523.0863.5274.1933.5132.4471.9912.5042.5421.1111.0081.6731.7290.1320.0010
Total Current Assets 35.29239.47143.34147.42651.04255.16858.72362.0265.66367.66372.71676.33782.13182.48420.23722.47525.5980.7661.2330.445
Non-Current Assets:
Property, Plant & Equipment, Net 0.2630.2370.280.320.3580.3090.0960.1270.1580.180.2160.2520.2830.020.0220.0180.0150.0080.0090
Goodwill 00000000000000000000
Intangible Assets 00000000000000000000
Goodwill and Intangible Assets 00000000000000000000
Long Term Investments 000000000.5410.5411100000000
Tax Assets 00000000000000000000
Other Non-Current Assets 0.0320.0260.0260.0260.0260.0330.0180.0180.0180.0180.0180.0180.01800.101000.2630.191-0.445
Total Non-Current Assets 0.2950.2630.3060.3460.3840.3420.1140.1450.7170.7391.2341.270.3010.020.1230.0180.0150.2720.2-0.445
Total Assets 35.58739.73443.64847.77251.42655.50958.83662.16466.3868.40373.9577.60682.43282.50520.3622.49325.6131.0381.4330
Liabilities & Equity:
Current Liabilities:
Account Payables 4.4373.7752.5052.0852.8532.6742.7453.0475.1742.9192.1741.6371.0940.6650.4320.8060.4680.4390.4780
Short Term Debt 0.1640.1780.1730.1680.1630.120.0530.0920.1310.1550.1520.1490.1460000.1030.05300
Tax Payables 00000000000000000000
Deferred Revenue -4.437-3.775-0.002-2.085-2.853-2.674-2.745-3.047-5,173.588-2.919-2,326.167-1.63700000-0.43900
Other Current Liabilities 4.4373.7750.0022.0852.8532.6742.7453.0475,173.58802,326.16701.44800.120.0091.7060.0090.0110
Total Current Liabilities 4.6013.9532.6782.2533.0162.7932.7983.1395.3043.0742.3261.7862.6880.6650.5520.8152.2770.5020.4890
Non-Current Liabilities:
Long Term Debt 0.0550.0160.0610.1070.1510.14152.8992.023130.7050.0130.0530.0920.1310.1090.1090.1090.109000
Deferred Revenue Non-Current 00000000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000000
Other Non-Current Liabilities -0-0-0-0-00-52.837-91.931-125.40100000000000
Total Non-Current Liabilities 0.0550.0160.0610.1070.1510.1410.0530.0925.3040.0130.0530.0920.1310.1090.1090.1090.109000
Total Liabilities 4.6553.9692.742.363.1672.9342.7983.1395.3043.0872.3791.8782.8190.7730.6610.9232.3850.5020.4890
Equity:
Preferred Stock 0000000000000000000.0140.007
Common Stock 0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00100.0110
Retained Earnings -65.645-60.685-55.244-51.058-47.897-43.151-39.283-35.902-33.637-29.145-25.023-21.483-17.429-15.112-12.66-9.764-8.062-7.229-6.7520
Accumulated Other Comprehensive Income/Loss -0.0070.002-0.107-0.139-0.262-0.3-0.371-0.435-0.348-0.311-0.093-0.103-0.0480-0-0-000-0.209
Other Total Stockholders Equity 96.58296.44796.25996.60896.41796.02595.69195.36195.0694.7796.68697.31397.08896.84332.35831.33331.297.7657.670
Total Shareholders Equity 30.93135.76540.90845.41248.25952.57556.03859.02561.07665.31571.57175.72979.61381.73219.69921.5723.2280.5360.943-0.202
Total Equity 30.93135.76540.90845.41248.25952.57556.03859.02561.07665.31571.57175.72979.61381.73219.69921.5723.2280.5360.943-0.202
Total Liabilities & Shareholders Equity 35.58739.73443.64847.77251.42655.50958.83662.16466.3868.40373.9577.60682.43282.50520.3622.49325.6131.0381.433-0.202